Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-quinoline-6-carboxamide monohydrate

EU orphan designation number: EU/3/13/1109   
Active ingredient: 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-quinoline-6-carboxamide monohydrate
Indication: Treatment of hepatocellular carcinoma
Sponsor: Eli Lilly Nederland B.V.
Grootslag 1-5, NL-3991 RA Houten, Nederland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/03/2013 Centralised Orphan - Designation EMA/OD/159/12 (2013)1602 of 13/03/2013
04/07/2013 Corrigendum (2013)1602 cor of 13/03/2013